ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY INVITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)

被引：0
|
作者：
WALDMANN, H
HALE, G
CIVIDALLI, G
WESHLER, Z
MANOR, D
RACHMILEWITZ, EA
POLLIAK, A
OR, R
WEISS, L
SAMUEL, S
BRAUTBAR, C
SLAVIN, S
机构：
[1] HADASSAH UNIV HOSP,BONE MARROW TRANSPLANTAT & CRYOPRESERVAT UNIT,IL-91120 JERUSALEM,ISRAEL
[2] HADASSAH UNIV HOSP,DEPT MED A,IMMUNOBIOL RES LAB,IL-91120 JERUSALEM,ISRAEL
[3] HADASSAH UNIV HOSP,DEPT PEDIAT,IL-91120 JERUSALEM,ISRAEL
[4] HADASSAH UNIV HOSP,TISSUE TYPING UNIT,IL-91120 JERUSALEM,ISRAEL
[5] HADASSAH UNIV HOSP,DEPT RADIOTHERAPY,IL-91120 JERUSALEM,ISRAEL
[6] HADASSAH UNIV HOSP,DEPT HEMATOL,IL-91120 JERUSALEM,ISRAEL
[7] UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND
来源：
LANCET | 1984年 / 2卷 / 8401期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：483 / 486
页数：4
相关论文
共 50 条
  • [21] Decreasing chronic graft-versus-host disease by adding median dose of rabbit anti-human lymphocyte globulin in conditioning regime.
    Wu, BY
    Guo, KY
    Song, CY
    Zhang, A
    Yan, DG
    Xiao, LL
    BLOOD, 2003, 102 (11) : 426B - 426B
  • [22] Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody
    Hatano, Ryo
    Ohnuma, Kei
    Yamamoto, Junpei
    Dang, Nam H.
    Yamada, Taketo
    Morimoto, Chikao
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 263 - 277
  • [23] Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody
    Ratanatharathorn, V
    Ayash, L
    Reynolds, C
    Silver, S
    Reddy, P
    Becker, M
    Ferrara, YLM
    Uberti, JP
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (08) : 505 - 511
  • [24] T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
    JACOBS, P
    WOOD, L
    WALDMANN, H
    HALE, G
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 679 - 679
  • [25] Anti-fractalkine monoclonal antibody therapy ameliorates murine sclerodermatous chronic graft-versus-host disease
    Utsunomiya, A.
    Luong, V. Huy
    Chino, T.
    Oyama, N.
    Matsushita, T.
    Ishii, N.
    Ogasawara, H.
    Toshio, I.
    Hasegawa, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S149 - S149
  • [26] T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
    JACOBS, P
    WOOD, L
    FULLARD, L
    WALDMANN, H
    HALE, G
    BONE MARROW TRANSPLANTATION, 1994, 13 (06) : 763 - 769
  • [27] TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH A NONMITOGENIC ANTI-CD3 MONOCLONAL-ANTIBODY
    ANASETTI, C
    MARTIN, PJ
    STORB, R
    APPELBAUM, FR
    BEATTY, PG
    DAVIS, J
    DONEY, K
    HILL, HF
    STEWART, P
    SULLIVAN, KM
    WITHERSPOON, RP
    THOMAS, ED
    HANSEN, JA
    TRANSPLANTATION, 1992, 54 (05) : 844 - 851
  • [28] Treatment of refractory chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody
    Guidi, S
    Bartolozzi, B
    Nozzoli, C
    Guglielmelli, P
    Lombardini, L
    Saccardi, R
    Vannucchi, AM
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S92 - S93
  • [29] Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death
    Hartwig, UF
    Robbers, M
    Wickenhauser, C
    Huber, C
    BLOOD, 2002, 99 (08) : 3041 - 3049
  • [30] Prevention of graft-versus-host disease by anti-1L-7Rα antibody
    Chung, Brile
    Dudl, Eric P.
    Min, Dullei
    Barsky, Lora
    Smiley, Nancy
    Weinberg, Kenneth I.
    BLOOD, 2007, 110 (08) : 2803 - 2810
12345